New York State Common Retirement Fund Crinetics Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 155,426 shares of CRNX stock, worth $5.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
155,426
Previous 147,691
5.24%
Holding current value
$5.17 Million
Previous $7.55 Million
5.3%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding CRNX
# of Institutions
255Shares Held
89.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$302 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$231 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$207 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$204 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$180 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.79B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...